InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EVO | Ann: Becoming a substantial holder | 27/12/18 | 0 | 308 | |||
|
|||||||
EVO | Ann: Half Yearly Report and Accounts | 17/12/18 | 0 | 396 | |||
|
|||||||
EVO | Ann: Initial Director's Interest Notice | 04/12/18 | 0 | 131 | |||
|
|||||||
EVO | Ann: Half Yearly Report and Accounts | 28/11/18 | 0 | 197 | |||
|
|||||||
EVO | Ann: Evolve - Interim Results announcement date | 26/11/18 | 0 | 155 | |||
|
|||||||
EVO | Ann: Ceasing to be a substantial holder | 29/10/18 | 0 | 145 | |||
|
|||||||
EVO | Ann: Change in substantial holding from NAB | 13:44 | 0 | 132 | |||
|
|||||||
EVO | Ann: Evolve announces appointment of GM Centre Operations | 19/09/18 | 0 | 204 | |||
|
See All Discussions